According to a factsheet published by the Trump administration, pharmaceuticals ...
Boehringer Ingelheim subsidiary NBE Therapeutics has opened its new antibody-dru...
Apellis Pharmaceuticals has announced US FDA acceptance of the sNDA and the gran...
GlobalData predicts that tirzepatide is likely to be increasingly prescribed for...
Is 'nearshoring', the preference among pharma and biotech to move operations to ...
In 2025, the CNS market is forecast to surpass $80bn in sales for the first time...
A federal judge in Houston has rejected the third attempt by J&J subsidiary Red ...
US-based Johnson & Johnson (J&J) has announced that it will be investing $55bn i...
Platform trials offer increased flexibility and reduced costs for sponsors and C...
BioVersys has announced the grant of key patent claims in China for the BV100 te...
The formulation allows for greater stockpiling, with Bavarian Nordic already wor...
Bioconjugation presents an new frontier for pharmaceutical development, providin...
Ionis has entered a licence agreement with Sobi in which the latter obtains excl...
GLP-1RAs were the big game changer, boosting average forecast sales and return o...
